Even as results from related research were published in the Nature journal, the outcome was never made public by the doctors or their institutions.

Zilong Qiu is now being investigated by his university more than a year after his patient likely died from his team's experimental gene-editing therapy.

The death of a six-year-old patient in an investigator-initiated study highlights systemic vulnerabilities in ethics reviews, animal-testing protocols and the financing of…